{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:29:23Z","timestamp":1787671763756,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"<jats:p>\n                    Neurofibromatosis type 1 (NF1) is a congenital disease which is caused by mutations in the\n                    <jats:italic toggle=\"yes\">NF1<\/jats:italic>\n                    gene on chromosome 17, resulting in an altered function of the neurofibromin protein. Owing to the ubiquitous expression of this protein, this syndrome is associated with pathology in many organ systems of the body, especially the central and peripheral nervous, musculoskeletal, and integumentary systems. This review outlines the common sequelae related to a diagnosis of NF1 and the common treatment approach to each.\n                  <\/jats:p>","DOI":"10.5435\/jaaos-d-22-00076","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T19:00:24Z","timestamp":1668798024000},"page":"e1495-e1503","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Orthopaedic Manifestations of Neurofibromatosis Type I"],"prefix":"10.5435","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1205-0059","authenticated-orcid":false,"given":"Timothy J.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odion","family":"Binitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250524","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet A"},{"key":"R2-20250524","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/jid.2014.465","article-title":"Incidence and mortality of neurofibromatosis: A total population study in Finland","volume":"135","author":"Uusitalo","year":"2015","journal-title":"J Invest Dermatol"},{"key":"R3-20250524","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/gim.2013.163","article-title":"Jaffe-Campanacci syndrome, revisited: Detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder","volume":"16","author":"Stewart","year":"2014","journal-title":"Genet Med"},{"key":"R4-20250524","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1474-4422(14)70063-8","article-title":"Neurofibromatosis type 1: A multidisciplinary approach to care","volume":"138","author":"Hirbe","year":"2014","journal-title":"Lancet Neurol"},{"key":"R5-20250524","doi-asserted-by":"crossref","first-page":"e20190660","DOI":"10.1542\/peds.2019-0660","article-title":"Health supervision for children with neurofibromatosis type 1","volume":"143","author":"Miller","year":"2019","journal-title":"Pediatrics"},{"key":"R6-20250524","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","article-title":"Distinctive cancer associations in patients with neurofibromatosis type 1","volume":"34","author":"Uusitalo","year":"2016","journal-title":"J Clin Oncol"},{"key":"R7-20250524","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1203\/PDR.0b013e3181a1c607","article-title":"Ras dependent paracrine secretion of osteopontin by Nf1+\/- osteoblasts promote osteoclast activation in a neurofibromatosis type I murine model","volume":"65","author":"Li","year":"2009","journal-title":"Pediatr Res"},{"key":"R8-20250524","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/jbmr.1992","article-title":"Hyperactive transforming growth factor-\u03b21 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model","volume":"2812","author":"Rhodes","year":"2013","journal-title":"J Bone Miner Res"},{"key":"R9-20250524","first-page":"1","article-title":"Neurofibromatosis in children","volume":"218","author":"Crawford","year":"1986","journal-title":"Acta Orthop Scand Suppl"},{"key":"R10-20250524","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13023-019-1196-0","article-title":"Identification and characterization of Nf1 and non-Nf1 congenital pseudarthrosis of the tibia based on germline Nf1 variants: Genetic and clinical analysis of 75 patients","volume":"14","author":"Zhu","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"R11-20250524","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U","article-title":"Type 1 neurofibromatosis: A descriptive analysis of the disorder in 1, 728 patients","volume":"70","author":"Friedman","year":"1997","journal-title":"Am J Med Genet"},{"key":"R12-20250524","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/humu.23783","article-title":"Neurofibromatosis type 1-related pseudarthrosis: Beyond the pseudarthrosis site","volume":"40","author":"Brekelmans","year":"2019","journal-title":"Hum Mutat"},{"key":"R13-20250524","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bone.2017.10.012","article-title":"The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent","volume":"106","author":"Tahaei","year":"2018","journal-title":"Bone"},{"key":"R14-20250524","first-page":"1","article-title":"Non-ossifying fibroma, fibrous cortical defect and Jaffe-Campanacci syndrome: A biologic and clinical review","volume":"93","author":"Mankin","year":"2009","journal-title":"Chir Organi Mov"},{"key":"R15-20250524","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2106\/JBJS.20.00999","article-title":"The natural history of benign bone tumors of the extremities in asymptomatic children: A longitudinal radiographic study","volume":"103","author":"Collier","year":"2021","journal-title":"J Bone Joint Surg Am"},{"key":"R16-20250524","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/1471-2474-15-218","article-title":"Multiple non-ossifying fibromas as a cause of pathological femoral fracture in Jaffe-Campanacci syndrome","volume":"15","author":"Cherix","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"R17-20250524","doi-asserted-by":"crossref","first-page":"e228170","DOI":"10.1136\/bcr-2018-228170","article-title":"Pathological fracture of non-ossifying fibroma associated with neurofibromatosis type 1","volume":"12","author":"Gill","year":"2019","journal-title":"BMJ Case Rep"},{"key":"R18-20250524","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jocn.2020.05.014","article-title":"Clinical and neuroradiological characterisation of spinal lesions in adults with Neurofibromatosis type 1","volume":"77","author":"Curtis-Lopez","year":"2020","journal-title":"J Clin Neurosci"},{"key":"R19-20250524","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1080\/02688697.2019.1673313","article-title":"The association of spinal deformity with dural ectasia in neurofibromatosis type 1","volume":"33","author":"Shah","year":"2019","journal-title":"Br J Neurosurg"},{"key":"R20-20250524","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00586-004-0829-7","article-title":"Spinal deformity in neurofibromatosis type-1: Diagnosis and treatment","volume":"14","author":"Tsirikos","year":"2005","journal-title":"Eur Spine J"},{"key":"R21-20250524","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s00381-020-04754-9","article-title":"Spinal manifestations of neurofibromatosis type 1","volume":"3610","author":"Shofty","year":"2020","journal-title":"Child Nerv Syst"},{"key":"R24-20250524","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2017.05.010","article-title":"Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview","volume":"67","author":"Miettinen","year":"2017","journal-title":"Hum Pathol"},{"key":"R25-20250524","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/humu.23552","article-title":"Analysis of intratumor heterogeneity in Neurofibromatosis type 1 plexiform neurofibromas and neurofibromas with atypical features: Correlating histological and genomic findings","volume":"39","author":"Carrio","year":"2018","journal-title":"Hum Mutat"},{"key":"R26-20250524","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/gcc.20921","article-title":"Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors","volume":"50","author":"Beert","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"R27-20250524","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/neuonc\/noz028","article-title":"Low mutation burden and frequent loss of CDKN2A\/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas","volume":"21","author":"Pemov","year":"2019","journal-title":"Neuro Oncol"},{"key":"R28-20250524","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejca.2019.10.014","article-title":"A nationwide cohort study on treatment and survival in patients with malignant peripheral nerve sheath tumours","volume":"124","author":"Martin","year":"2020","journal-title":"Eur J Cancer"},{"key":"R29-20250524","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2319\/021411-108.1","article-title":"Prevalence and severity of vestibular recession in mandibular incisors after orthodontic treatment","volume":"82","author":"Vasconcelos","year":"2012","journal-title":"Angle Orthod"},{"key":"R31-20250524","doi-asserted-by":"crossref","first-page":"e28138","DOI":"10.1002\/pbc.28138","article-title":"Neurofibromatosis-associated malignant peripheral nerve sheath tumors in children have a worse prognosis: A Nationwide cohort study","volume":"67","author":"Martin","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"R32-20250524","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejca.2015.12.015","article-title":"Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French sarcoma group (GSF-GETO)","volume":"56","author":"Valentin","year":"2016","journal-title":"Eur J Cancer"},{"key":"R33-20250524","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/ng.3095","article-title":"PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors","volume":"46","author":"Lee","year":"2014","journal-title":"Nat Genet"},{"issue":"suppl 1","key":"R34-20250524","first-page":"i50","article-title":"Genetics of human malignant peripheral nerve sheath tumors","volume":"2","author":"Pemov","year":"2020","journal-title":"Neurooncol Adv"},{"key":"R35-20250524","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/path.5507","article-title":"H3k27me3 expression and methylation status in histological variants of malignant peripheral nerve sheath tumours","volume":"252","author":"Lyskjaer","year":"2020","journal-title":"J Pathol"},{"key":"R36-20250524","first-page":"172","article-title":"National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, MD, USA, July 13-15, 1987","volume":"1","year":"1988","journal-title":"Neurofibromatosis"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-22-00076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:48:47Z","timestamp":1787669327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-22-00076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":33,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-22-00076","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"2022-02-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}